1st Quarter - Report
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRYANT HALL | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
Taxation/Internal Revenue Code TAX
Issues related to the orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRYANT HALL | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
| ANDREW MCKECHNIE | — |
| JOHN KIRKLAND TWOMEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.